Editas Medicine (EDIT) Misses Q3 EPS by 4c

Editas Medicine (NASDAQ: EDIT) reported Q3 EPS of ($0.64), $0.04 worse than the analyst estimate of ($0.60).

For earnings history and earnings-related data on Editas Medicine (EDIT) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Credo Technology pops 3.5% as Evercore initiates with monster $325 price target
• Morgan Stanley sees little room left in steel rally, cuts Cleveland-Cliffs rating